Please click on the ID to see detailed information about each entry.
The total number entries retrieved from this search areID1028 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1029 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1030 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>1% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1031 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1032 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1033 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>1.5% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1034 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~2% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1035 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<4% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1036 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~0.5% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1037 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<1% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1038 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>8% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1039 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<4% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1040 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability<18% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1041 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1042 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>8% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1043 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1044 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~6% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1045 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~1.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1046 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1047 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1048 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~2% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1049 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~7% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1050 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1051 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability2% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |
ID1052 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~11% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1053 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~9% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1054 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~3% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1055 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~10% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1056 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~7% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1057 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~5% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1058 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~12% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1059 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>4% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1060 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~4% of applied dose | Tissue SampleEpidermis of human breast skin | PUBMED ID22890441 |
ID1061 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>36% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1062 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>26% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1063 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~26% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1064 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability25% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1065 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability20% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1066 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~20% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1067 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~26% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1068 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability13% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1069 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability14% of applied dose | Tissue SampleDermis of human breast skin | PUBMED ID22890441 |
ID1070 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability9.5% of applied dose | Tissue SampleAcceptor compartment of Franz diffusion cell | PUBMED ID22890441 |
ID1071 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~7% of applied dose | Tissue SampleAcceptor compartment of Franz diffusion cell | PUBMED ID22890441 |
ID1072 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>19% of applied dose | Tissue SampleAcceptor compartment of Franz diffusion cell | PUBMED ID22890441 |
ID1073 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability21% of applied dose | Tissue SampleAcceptor compartment of Franz diffusion cell | PUBMED ID22890441 |
ID1074 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability>8% of applied dose | Tissue SampleAcceptor compartment of Franz diffusion cell | PUBMED ID22890441 |
ID1075 | Sequenceβ-Ala-H | NameN-acetyl- L -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~15% of applied dose | Tissue SampleAcceptor compartment of Franz diffusion cell | PUBMED ID22890441 |
ID1546 | Sequenceβ-Ala-H | NameL -carnosine | Nature of peptide or cargoAntioxidant | AssayFranz diffusion cell, HPLC | Tissue permeability~0.5% of applied dose | Tissue SampleStratum corneum of human breast skin | PUBMED ID22890441 |